HETEROGENEITY OF THE 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE EFFICACY DUE TO VARIOUS UNDERLYING CONDITIONS OF CHRONIC PULMONARY DISEASE IN ELDERLY PATIENTS

被引:0
|
作者
Inoue, S. [1 ]
Kaneko, T. [2 ]
Morita, S. [2 ]
Natsumeda, Y. [3 ]
Mizushima, S. [1 ]
机构
[1] Yokohama City Univ, Grad Sch Med, Dept Epidemiol & Publ Hlth, Yokohama, Kanagawa 232, Japan
[2] Yokohama City Univ, Grad Sch Med, Dept Biostat & Epidemiol, Yokohama, Kanagawa 232, Japan
[3] Yokohama City Univ, Grad Sch Med, Lab Clin Res, Yokohama, Kanagawa 232, Japan
关键词
D O I
10.1136/jech.2011.142976d.71
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
引用
收藏
页码:A115 / A115
页数:1
相关论文
共 50 条
  • [11] Impact and effectiveness of 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in the elderly in England and Wales
    Andrews, Nick J.
    Waight, Pauline A.
    George, Robert C.
    Slack, Mary P. E.
    Miller, Elizabeth
    VACCINE, 2012, 30 (48) : 6802 - 6808
  • [12] IMMUNOGENICITY AND SAFETY OF 23-VALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE IN PATIENTS WITH SPONDYLOARTHRITIS
    Muravyeva, N.
    Belov, B.
    Baranova, M.
    Cherkasova, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 854 - 855
  • [13] The Efficacy of 23-Valent Pneumococcal Polysaccharide Vaccine in Preventing Pneumonia and Invasive Pneumococcal Disease in the Elderly Aged 75 Years and Older in Taiwan
    Hsieh, Meng-Jer
    Tsai, Ying-Huang
    Chang, Chee-Jen
    Wen, Yu-Wen
    Hu, Han-Chung
    Chao, Yen-Nan
    Huang, Yhu-Chering
    Yang, Cheng-Ta
    Huang, Chung-Chi
    CHEST, 2013, 144 (04)
  • [14] Safety of concomitant administration of 23-valent polysaccharide pneumococcal vaccine and influenza vaccine among the elderly
    Won, Heehyun
    Kim, Jeong Ah
    Jeong, Na-Young
    Choi, Nam-Kyong
    VACCINE, 2024, 42 (13) : 3190 - 3196
  • [15] Safety of concomitant administration of 23-valent polysaccharide pneumococcal vaccine and influenza vaccine among the elderly
    Won, Heehyun
    Kim, Jeong Ah
    Jeong, Na-Young
    Choi, Nam-Kyong
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 24 - 25
  • [16] Immune response to the 23-valent pneumococcal polysaccharide vaccine in lymphoma patients and patients with chronic renal diseases
    Kuhnemund, O
    Stutz, A
    Fuchshuber, A
    Querfeld, U
    Petrasch, S
    Reinert, RR
    Lutticken, R
    STREPTOCOCCI AND THE HOST, 1997, 418 : 837 - 839
  • [17] SAFETY OF 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Tarasova, G.
    Belov, B.
    Cherkasova, M.
    Aseeva, E.
    Reshetnyak, T.
    Kosheleva, N.
    Popkova, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1180 - 1180
  • [18] INFLUENCE OF VARIOUS FACTORS ON THE IMMUNOGENICITY OF 23-VALENT POLYSACCHARIDE PNEUMOCOCCAL VACCINE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Tarasova, G.
    Belov, B.
    Cherkasova, M.
    Aseeva, E.
    Reshetnyak, T.
    Kosheleva, N.
    Popkova, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 614 - 615
  • [19] Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease in Navajo adults
    Benin, A
    O'Brien, K
    Watt, J
    Reid, R
    Zell, ER
    Katz, S
    Donaldson, C
    Parkinson, A
    Schuchat, A
    Santosham, M
    Whitney, CG
    CLINICAL INFECTIOUS DISEASES, 2001, 33 (07) : 1148 - 1148
  • [20] TOLERABILITY, EFFICACY AND IMMUNOGENICITY OF 23-VALENT PNEUMOCOCCAL VACCINE IN SLE PATIENTS
    Tarasova, G. M.
    Belov, B. S.
    Sergeeva, M. S.
    Soloviev, S. K.
    Aseeva, E. A.
    Klukvina, N. G.
    Popkova, T. V.
    Alexandrova, E. N.
    Novikov, A. A.
    Cherkasova, M. V.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1226 - 1226